| Q37288983 | A role for host activation-induced cytidine deaminase in innate immune defense against KSHV. |
| Q21131084 | AID and APOBECs span the gap between innate and adaptive immunity |
| Q36263411 | APOBEC3 Proteins in Viral Immunity. |
| Q36941097 | APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion |
| Q40848214 | APOBEC3 proteins and genomic stability: the high cost of a good defense |
| Q37264399 | APOBEC3 proteins can copackage and comutate HIV-1 genomes. |
| Q36031782 | APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans |
| Q41552553 | APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death |
| Q36100420 | APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair |
| Q59352288 | Antibody-dependent cellular cytotoxicity in HIV infection |
| Q36993967 | Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication |
| Q58594822 | Correlation of apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G genetic variant rs8177832 with HIV-1 predisposition in Pakistani Population |
| Q39037081 | DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies |
| Q84968420 | Damage control: how HIV survives the editor APOBEC3G |
| Q57565003 | Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu |
| Q42243641 | Estimating the fraction of progeny virions that must incorporate APOBEC3G for suppression of productive HIV-1 infection |
| Q26864489 | Evasion from NK cell-mediated immune responses by HIV-1 |
| Q34571277 | Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals |
| Q30418622 | HIV-1 Gag-virus-like particles inhibit HIV-1 replication in dendritic cells and T cells through IFN-α-dependent upregulation of APOBEC3G and 3F. |
| Q42031796 | HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain |
| Q38182066 | HIV-1 accessory proteins adapt cellular adaptors to facilitate immune evasion |
| Q38125575 | Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif. |
| Q27009024 | Host-pathogen interaction in HIV infection |
| Q27003079 | Immune surveillance of unhealthy cells by natural killer cells |
| Q36471212 | Immunosurveillance and immunotherapy of tumors by innate immune cells |
| Q38725490 | Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. |
| Q35760429 | In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice |
| Q54233000 | Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses. |
| Q38491184 | Innate immunity against HIV-1 infection |
| Q28068375 | Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells |
| Q90326890 | Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden |
| Q35993707 | Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response. |
| Q92703239 | Interplay between Intrinsic and Innate Immunity during HIV Infection |
| Q34615002 | Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system |
| Q55425287 | Keratinocyte differentiation induces APOBEC3A, 3B, and mitochondrial DNA hypermutation. |
| Q35022585 | Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo |
| Q27022978 | Molecular mechanisms of HIV immune evasion of the innate immune response in myeloid cells |
| Q38098383 | Molecular mechanisms of natural killer cell activation in response to cellular stress |
| Q26752833 | NK Cells in HIV Disease |
| Q42590545 | NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses |
| Q38457805 | Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis |
| Q90079629 | Potential of the NKG2D/NKG2DL Axis in NK Cell-Mediated Clearance of the HIV-1 Reservoir |
| Q34321457 | Regulation of ligands for the NKG2D activating receptor |
| Q38108820 | Regulation of self-ligands for activating natural killer cell receptors |
| Q60046078 | Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1 |
| Q36432758 | Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein |
| Q37598020 | T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System. |
| Q47600020 | The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir |
| Q38178966 | The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells. |
| Q41748165 | The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway |
| Q37126033 | The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection |
| Q21134793 | The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover |
| Q21563365 | The genetic architecture of adaptations to high altitude in Ethiopia |
| Q40130732 | The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity |
| Q38281980 | The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway |
| Q37978492 | The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest |
| Q41812539 | The role of cytidine deaminases on innate immune responses against human viral infections. |
| Q47552005 | Understanding the regulation of APOBEC3 expression: Current evidence and much to learn. |
| Q34733579 | Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA. |
| Q37638959 | Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes |
| Q41102793 | Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes |
| Q41624661 | Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production |
| Q35849480 | What's the damage? The impact of pathogens on pathways that maintain host genome integrity |